Ameritas Advisory Services’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-29
Closed -$1.06K 2597
2023
Q1
$1.06K Buy
+29
New +$1.01K ﹤0.01% 2535

Other funds holding ASTH

Ameritas Advisory Services's ASTH Position: Q2 2023 in Review

Ameritas Advisory Services sold out of Astrana Health (ASTH) in Q2 2023, closing a stake of 29 shares — an estimated $1.06K sold.

Ameritas Advisory Services first reported a position in ASTH in Q1 2023 and held it in 1 quarter. The position peaked at $1.06K in Q1 2023. 130 funds tracked by Wall St. Rank hold ASTH as of Q2 2023.

  • Ameritas Advisory Services reported no remaining Astrana Health position as of Q2 2023 after selling out during the quarter.
  • Ameritas Advisory Services sold 29 Astrana Health shares in Q2 2023, an estimated $1.06K.
  • Ameritas Advisory Services first reported a position in Astrana Health in Q1 2023 and held it in 1 quarter.
  • Ameritas Advisory Services's Astrana Health position peaked at $1.06K in Q1 2023.
  • 130 funds tracked by Wall St. Rank held Astrana Health as of Q2 2023.

Based on Ameritas Advisory Services's 13F filing for Q2 2023, filed 25 Jul 2023.